Alexandra Abreu
Analyst, Sofinnova Partners – Crossover Strategy
Alexandra joined Sofinnova Partners as an Analyst in the Crossover team in April 2024. She was previously a Venture Capital Fellow at Ysios Capital.
Alexandra came on board as she enjoys “seeing science translated into innovation that changes patients' lives, which is what we do every day at Sofinnova.”
Alexandra has a PhD in vascular biology from University College London (UCL), where she worked on vascular calcification in diabetic-associated peripheral arterial disease patients. She also has a MSc in Bioengineering from Imperial College London.
Sector
Biopharmaceuticals
